BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination
Status:
Completed
Trial end date:
2021-03-02
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to evaluate the efficacy and safety by comparing the
BR1010 treatment group to the fimasartan/amlodipine treatment group at Week 8 in patients
with essential hypertension who do not adequately respond to Fimasartan/Amlodipine
combination